Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Clofarabine salvage therapy for refractory high-risk langerhans cell histiocytosis.

Clofarabine salvage therapy for refractory high-risk langerhans cell histiocytosis. Pediatr Blood Cancer. 2013 Jun; 60(6):E19-22.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.